{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:20:17Z","timestamp":1794932417486,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP223fa627005"],"award-info":[{"award-number":["JP223fa627005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129048","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:53:59Z","timestamp":1786971239000},"page":"129048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel candidate vaccine virus derived from Japan's first mammalian case of clade 2.3.4.4b A\/H5N1 highly pathogenic avian influenza virus"],"prefix":"10.1016","volume":"91","author":[{"given":"Yasushi","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shirakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyo","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Iwata-Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129048_bb0005","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/v16121956","article-title":"Phylogenetic and pathogenic analysis of H5N1 and H5N6 high pathogenicity avian influenza virus isolated from poultry farms (layer and broiler chickens) in Japan in the 2023\/2024 season","volume":"16","author":"Nishiura","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2026.129048_bb0010","series-title":"Joint FAO\/WHO\/WOAH preliminary assessment of recent influenza A(H5N1) viruses","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129048_bb0015","doi-asserted-by":"crossref","first-page":"veae027","DOI":"10.1093\/ve\/veae027","article-title":"High pathogenic avian influenza a(H5) viruses of clade 2.3.4.4b in Europe-why trends of virus evolution are more difficult to predict","volume":"10","author":"Fusaro","year":"2024","journal-title":"Virus Evol"},{"key":"10.1016\/j.vaccine.2026.129048_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1625665","article-title":"Emerging threats of H5N1 clade 2.3.4.4b: cross-species transmission, pathogenesis, and pandemic risk","volume":"15","author":"Azeem","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.129048_bb0025","series-title":"Animal and plant health inspection service. Detections of highly pathogenic avian influenza (HPAI) in livestock","author":"US Department of Agriculture","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129048_bb0030","series-title":"H5 bird flu: current situation","author":"Centers for Disease Control and Prevention","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129048_bb0035","series-title":"Vaccines for pandemic influenza","author":"European Medicines Agency","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129048_bb0040","series-title":"Vaccines licensed for use in the United States","author":"U.S. Food and Drug Administration","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129048_bb0045","series-title":"Summary of zoonotic candidate vaccine viruses for southern hemisphere 2024","author":"WHO","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129048_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280811","article-title":"Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields","volume":"18","author":"Arita","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.129048_bb0055","series-title":"Questions and answers: recommended composition of influenza virus vaccines for use in the southern hemisphere 2026 influenza season and development of candidate vaccine viruses for pandemic preparedness","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129048_bb0060","series-title":"Guidelines for the safe development and production of vaccines to human pandemic influenza viruses and influenza viruses with pandemic potential, annex 3, TRS no 1016","author":"WHO","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129048_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2022.11.008","article-title":"Virological, pathological, and glycovirological investigations of an Ezo red fox and a tanuki naturally infected with H5N1 high pathogenicity avian influenza viruses in Hokkaido, Japan","volume":"578","author":"Hiono","year":"2023","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129048_bb0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/irv.12694","article-title":"Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds","volume":"14","author":"Harada","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.129048_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1750-2659.2009.00104.x","article-title":"Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production","volume":"3","author":"Dong","year":"2009","journal-title":"Influ Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.129048_bb0080","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.vaccine.2019.07.032","article-title":"CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses","volume":"37","author":"Tateishi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129048_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.129048_bb0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jviromet.2013.07.026","article-title":"Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying influenza a particles","volume":"193","author":"Bousse","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2026.129048_bb0095","author":"WHO"},{"key":"10.1016\/j.vaccine.2026.129048_bb0100","series-title":"Influenza reagent: influenza virus infectious NYMC X-263. NIBSC code: 15\/158. Instructions for use, version 2.0","author":"National Institute for Biological Standards and Control (NIBSC)","year":"2015"},{"key":"10.1016\/j.vaccine.2026.129048_bb0105","series-title":"R: a language and environment for statistical computing R foundation for statistical computing, Vienna, Austria","author":"R Core Team","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129048_bb0110","unstructured":"WHO. https:\/\/cdn.who.int\/media\/docs\/default-source\/influenza\/cvvs\/cvv-zoonotic-northern-hemisphere-2024-2025\/h5n1_summary_a_h5n1_cvv_20240223.pdf?sfvrsn=2d559bc4_5; 2024 [Accessed 16 October 2025]."},{"issue":"9","key":"10.1016\/j.vaccine.2026.129048_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129048_bb0120","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1128\/JVI.01522-07","article-title":"Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies","volume":"81","author":"Kaverin","year":"2007","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:51:25Z","timestamp":1794930685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0264410X26008571"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel candidate vaccine virus derived from Japan's first mammalian case of clade 2.3.4.4b A\/H5N1 highly pathogenic avian influenza virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129048"}}